Logo image
Clinical trial preparedness in facioscapulohumeral muscular dystrophy: Clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York
Journal article   Open access   Peer reviewed

Clinical trial preparedness in facioscapulohumeral muscular dystrophy: Clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York

Rabi Tawil, George W Padberg, Dennis W Shaw, Silvère M van der Maarel, Stephen J Tapscott and FSHD Workshop Participants
Neuromuscular disorders : NMD, Vol.26(2), pp.181-186
02/2016
DOI: 10.1016/j.nmd.2015.10.005
PMID: 26627872
url
https://doi.org/10.1016/j.nmd.2015.10.005View
Published (Version of record) Open Access

Abstract

•Many national registries now exist facilitating patient access to trials.•New functional and patient reported outcome measure is being validated.•More research is required to establish reliable tissue and serum biomarkers.•Longitudinal muscle MRI studies suggest that imaging is a useful biomarker in FSHD.•Electrical impedance myography is reliable in certain muscle groups.

Details

Metrics

Logo image